Literature DB >> 9210909

Resistance to activated protein C and Arg 506 Gln factor V mutation are uncommon in eastern Asian populations.

H Kodaira1, F Ishida, S Shimodaira, O Takamiya, K Furihata, K Kitano.   

Abstract

We investigated the prevalence of the factor V (FV) Arg 506 Gln mutation in healthy subjects from three eastern Asian countries (Japan, n = 270; China, n = 113; and Korea, n = 93) and in 26 Japanese patients showing venous thromboembolic events. The patients were also examined for activated protein C (APC) resistance by using the Coatest APC resistance kit. The FV mutation was investigated by polymerase chain reaction and restricted enzyme digestion with MnlI RFLP assay of the FV gene. None of the patients showed APC resistance, while all subjects examined were homozygous for Arg at position 506 of the FV gene. Our results imply that FV mutation and APC resistance contribute little to venous thrombotic diseases in eastern Asia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9210909     DOI: 10.1159/000203548

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  3 in total

1.  An age-related decrease in factor V Leiden frequency among Polish subjects.

Authors:  G Adler; M Parczewski; E Czerska; B Loniewska; M Kaczmarczyk; J Gumprecht; W Grzeszczak; A Szybinska; M Mossakowska; A Ciechanowicz
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

2.  Epidemiology of activated protein C resistance and factor v leiden mutation in the mediterranean region.

Authors:  Mehrez M Jadaon
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-09-08       Impact factor: 2.576

3.  The relationship between thrombophilic mutations and preeclampsia: a prospective case-control study.

Authors:  Ahmet Yalinkaya; Mahmut Erdemoglu; Nurten Akdeniz; Ahmet Kale; Ebru Kale
Journal:  Ann Saudi Med       Date:  2006 Mar-Apr       Impact factor: 1.526

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.